Buchumschlag

High expression of autotaxin is associated with poor recurrence‐free survival in cholangiocarcinoma

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Xuefeng Li, Yukinori Koyama, Kojiro Taura, Takahiro Nishio, Tomoaki Yoh, Hiroto Nishino, Yusuke Uemoto, Yusuke Kimura, Daichi Nakamura, Nguyen Hai Nam, Motohiko Sato, Satoru Seo, Keiko Iwaisako, Etsuro Hatano
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Hepatology Research
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Defining advanced lymph node metastasis in intrahepatic cholangiocarcinoma: A multicenter study
von: Makoto Kurimoto, et al.
Veröffentlicht: (2025)

A classification model for resectability in hepatocellular carcinoma patients
von: Ikuo Nakamura, et al.
Veröffentlicht: (2024)

ALDH2 Polymorphism in Alcohol‐Related Cirrhosis Requiring Liver Transplantation: A Recipient–Donor Analysis
von: Noriyo Yamashiki, et al.
Veröffentlicht: (2026)

Impact of hepatitis C virus infection control on preventing the postoperative recurrence of intrahepatic cholangiocarcinoma
von: Takashi Kokudo, et al.
Veröffentlicht: (2025)

Value of autotaxin for hepatocellular carcinoma risk assessment in chronic hepatitis B patients treated with nucleos(t)ide analogs
von: Yuichi Hiyama, et al.
Veröffentlicht: (2024)

Regeneration of the Human Intrahepatic Nervous System in Living Donor Liver Transplantation Recipients
von: Yusuke Hanabata, et al.
Veröffentlicht: (2026)

Impact of Surgical Resection on Hepatocellular Carcinoma Following Systemic Drug Therapy: A Multicenter Retrospective Observational Study
von: Takamichi Ishii, et al.
Veröffentlicht: (2025)

Molecular biological role of epithelial splicing regulatory protein 1 in intrahepatic cholangiocarcinoma
von: Takahiro Haruna, et al.
Veröffentlicht: (2024)

Fibroblast growth factor receptor 2 alterations in intrahepatic cholangiocarcinoma: Prevalence and clinical implications in Asian populations
von: Kyoko Oura, et al.
Veröffentlicht: (2025)

Apparent diffusion coefficient in intrahepatic cholangiocarcinoma diffusion‐weighted magnetic resonance imaging noninvasively predicts Ki‐67 expression
von: Daiki Hokkoku, et al.
Veröffentlicht: (2024)

Multicenter observational study to characterize fibroblast growth factor receptor 2 fusions or rearrangements in patients with advanced/metastatic cholangiocarcinoma
von: Tomoyuki Satake, et al.
Veröffentlicht: (2025)

Switching from combination therapy with entecavir hydrate plus tenofovir alafenamide fumarate to tenofovir alafenamide fumarate monotherapy in patients with chronic hepatitis B based on nucleotide sequences of hepatitis B virus pregenome RNA
von: Shunsuke Yamada, et al.
Veröffentlicht: (2024)

Lenvatinib Versus Atezolizumab Plus Bevacizumab as First‐Line Treatment for Advanced Hepatocellular Carcinoma With a CRAFITY Score of 2: A Multi‐Center Retrospective Study
von: Masayuki Ueno, et al.
Veröffentlicht: (2025)

White‐Light Imaging and Image‐Enhanced Endoscopy With Magnifying Endoscopy for the Optical Diagnosis of Superficial Nonampullary Duodenal Epithelial Tumors: A Systematic Review and Meta‐Analysis
von: Masao Yoshida, et al.
Veröffentlicht: (2024)

Mac‐2 Binding Protein Glycosylation Isomer as a Dynamic Biomarker in Obstructive Cholestasis
von: Takanobu Iwadare, et al.
Veröffentlicht: (2025)

Steatotic Liver Disease and the “Point of No Return” in the Development of Metabolic Disorders
von: Tsutomu Nishida, et al.
Veröffentlicht: (2026)

Is Glucose Intolerance a Precursor of Cachexia in Patients With Liver Cirrhosis?
von: Tsutomu Nishida, et al.
Veröffentlicht: (2025)

Efficacy of steroid therapy for improving native liver survival after pediatric acute liver failure with immune activation
von: Hiroshi Oue, et al.
Veröffentlicht: (2024)

Development of irreversible pancreatic ductal change triggered by pancreatic duct stenting in chronic pancreatitis
von: Kensuke Takuma, et al.
Veröffentlicht: (2024)

Differences in Clinical Characteristics Between Missed and Detected Laryngopharyngeal Cancers
von: Yusuke Kumazawa, et al.
Veröffentlicht: (2025)

Low‐power pure‐cut hot snare polypectomy for colorectal polyps 10–14 mm in size: a multicenter retrospective study
von: Hidenori Kimura, et al.
Veröffentlicht: (2024)

Optimal treatment strategy and prognostic analysis of salvage liver transplantation for patients with early hepatocellular carcinoma recurrence after hepatectomy
von: Hao‐Chien Hung, et al.
Veröffentlicht: (2024)

Prognostic performance of a two‐step method using the Fibro‐Scope system for metabolic dysfunction‐associated steatotic liver disease
von: Yuya Seko, et al.
Veröffentlicht: (2024)

Deciphering metabolic dysfunction‐associated steatotic liver disease: insights from predictive modeling and clustering analysis
von: Kazuma Mori, et al.
Veröffentlicht: (2024)

Gastrointestinal: Colorectal metastases from gastric poorly differentiated carcinoma presenting as a diminutive polyp
von: K Shiotsuki, et al.
Veröffentlicht: (2024)

Development of Deep Learning–Based Virtual Lugol Chromoendoscopy for Superficial Esophageal Squamous Cell Carcinoma
von: Yosuke Toya, et al.
Veröffentlicht: (2024)

Investigation of the effects of a new transdermal formulation of systemic diclofenac on the upper gastrointestinal mucosa in patients with low back pain: A comparative study with oral diclofenac
von: Hiroyuki Fukase, et al.
Veröffentlicht: (2024)

Efficacy and Safety of Direct Oral Anticoagulants in Budd–Chiari Syndrome After Percutaneous Recanalization
von: Chengjian Wu, et al.
Veröffentlicht: (2025)

Immune‐related adverse event detection in liver cancer patients treated with immune checkpoint inhibitors: Nationwide exploratory survey in Japan
von: Masako Shomura, et al.
Veröffentlicht: (2024)

Metabolic dysfunction‐associated steatotic liver disease (SLD) and alcohol‐associated liver disease, but not SLD without metabolic dysfunction, are independently associated with new onset of chronic kidney disease during a 10‐year follow‐up period
von: Kazuma Mori, et al.
Veröffentlicht: (2024)

Exploring a Subpopulation of MASLD Associated With New Onset of CKD Using Supervised Clustering Techniques
von: Itaru Hosaka, et al.
Veröffentlicht: (2026)

The association between proton‐pump inhibitor use and recurrence of hepatocellular carcinoma after hepatectomy
von: Chun‐Ting Ho, et al.
Veröffentlicht: (2024)

A low baseline serum myostatin concentration is associated with poor clinical outcome in patients with primary biliary cholangitis
von: Manabu Hayashi, et al.
Veröffentlicht: (2024)

Predictive Factors for Technical Difficulty During Endoscopic Submucosal Dissection of Superficial Barrett's Esophageal Adenocarcinoma
von: Koyo Kido, et al.
Veröffentlicht: (2026)

Grip strength is a strong indicator of osteoporosis in both women and men with chronic liver disease
von: Tatsuki Ichikawa, et al.
Veröffentlicht: (2025)

Significance of changes in tumor markers in patients treated with durvalumab plus tremelimumab combination therapy as a surrogate marker for tumor response to unresectable hepatocellular carcinoma
von: Shinsuke Uchikawa, et al.
Veröffentlicht: (2024)

Impact of muscle volume changes following atezolizumab‐bevacizumab therapy in patients with unresectable hepatocellular carcinoma
von: Hironori Ochi, et al.
Veröffentlicht: (2025)

Individualized Effects of Weight Gain in Adulthood on the Development of MASLD in Japanese Non‐Obese Individuals
von: Kaiji Fukamizo, et al.
Veröffentlicht: (2025)

Clinical course of small gastric subepithelial lesion less than 20 mm diagnosed by endoscopic ultrasound‐guided fine‐needle aspiration
von: Ryosuke Kobayashi, et al.
Veröffentlicht: (2024)

Newly established borderline resectable 1 (BR1) category is one of the favorable candidates for selecting the use of multidisciplinary combination therapy in patients with advanced hepatocellular carcinoma treated with systemic therapy
von: Yusuke Kawamura, et al.
Veröffentlicht: (2024)